How to buy Cardiva Medical Inc stock when it goes public

How to buy Cardiva Medical Inc stock when it starts trading

1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
2. Open your brokerage account. Complete an application with your details.
3. Confirm your payment details. Fund your account.
4. Research the stock. Find the stock by name or ticker symbol and research it before deciding if it's a good investment for you.
5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.

Finder's picks for buying Cardiva Medical Inc stock when it goes public

Best for beginners

Go to site

Commission-free stock trading

• No-cost financial planning and automated investing
• $0 commission on stocks, ETFs and options
• Get up to $1,000 in stock when you fund a new account within 30 days

Top pick for new account bonus

Go to site

$200 in US stocks

• Trade options, futures, options on futures, stocks, ETFs
• $0 commission to close options
• Get $100-$5,000 when you open an account with $5,000 to $1,000,000+

Top pick for interest on uninvested cash

Go to site

Easy access to diverse assets

• Trade stocks, bonds, options, ETFs, crypto, Treasurys, collectibles, royalties
• Earn 5.1% APY on your cash
• Earn a $0.18 rebate on options, with no commissions and no per-contract fees

How do similar companies perform?

It's impossible to predict how any stock will perform — and IPOs can be particularly volatile. Looking at the performance of similar companies can help you decide if now is a good time to buy Cardiva Medical Inc stock.

• AngioDynamics (ANGO.US)

  Company summary

  AngioDynamics, Inc. provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease. The company's thrombus management portfolio includes AlphaVac system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac circuit is indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. In addition, it offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. The company also provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

  Historical performance

  Stock information

  • Market capitalization: $232716640
  • PEG ratio: 1.87
  • Dividend yield: N/A%

  Get more detailed information and learn how to buy ANGO.US stock

• Teleflex Incorporated (TFX.US)

  Company summary

  Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

  Historical performance

  Stock information

  • Market capitalization: $9736289280
  • P/E ratio: 27.3065
  • PEG ratio: 2.4788
  • Dividend yield: 0.0066%

  Get more detailed information and learn how to buy TFX.US stock

• Merit Medical Systems (MMSI.US)

  Company summary

  Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

  Historical performance

  Stock information

  • Market capitalization: $4298522112
  • P/E ratio: 45.6975
  • PEG ratio: 1.9086
  • Dividend yield: N/A%

  Get more detailed information and learn how to buy MMSI.US stock

Compare trading platforms

1 - 6 of 6

Sort by:

Name	Product	Ratings	Available asset types	Minimum deposit	Stock trade fee	Cash sweep APY	Signup bonus
SoFi Invest® Finder Score: 4.2 / 5: ★★★★★ SoFi Invest® Finder Score: 4.2 / 5: ★★★★★		★★★★★	Stocks, Mutual funds, ETFs, Alternatives	$0	$0		Get up to $1,000 in stock when you fund a new Active Invest account	Go to site More Info		loading Fetching your data...
Tastytrade Finder Score: 4.6 / 5: ★★★★★ Tastytrade Finder Score: 4.6 / 5: ★★★★★		★★★★★	Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills	$0	$0	N/A	Get $100-$5,000 when you open and fund an account with $5,000 to $1,000,000+	Highly commended for Best Derivatives Trading Platform award.	Go to site More Info		loading Fetching your data...
Public.com Finder Score: 4.2 / 5: ★★★★★ Public.com Finder Score: 4.2 / 5: ★★★★★		★★★★★	Stocks, ETFs, Cryptocurrency, Art, Treasury Bills, Collectibles	$0	$0	5.1%	N/A	2.5% fee applies to all alternative asset transactions.	Go to site More Info		loading Fetching your data...
Robinhood Gold Finder Score: 4.3 / 5: ★★★★★ Robinhood Gold Finder Score: 4.3 / 5: ★★★★★		★★★★★	Stocks, Options, ETFs, Cryptocurrency	$0	$0	5%	Get a free stock when you successfully sign up and link your bank account.	Try Robinhood Gold for 30 days risk-free upon signup and earn a 5% APY on your uninvested cash, a 3% match on IRA contributions, up to $50,000 in instant deposits and more. Accounts are auto-downgraded after the trial period. Robinhood Gold is $5/month.	Go to site More Info		loading Fetching your data...
Moomoo Finder Score: 4.7 / 5: ★★★★★ Moomoo Finder Score: 4.7 / 5: ★★★★★ Exclusive		★★★★★	Stocks, Options, ETFs	$0	$0	5.10%	Choose a 1.5% match or 7 free fractional shares when you open a new account and meet funding requirements	No commission stock and ETF trading, with a chance to get a 1.5% cash reward match or 7 free fractional shares.	Go to site More Info		loading Fetching your data...
Robinhood Finder Score: 4.4 / 5: ★★★★★ Robinhood Finder Score: 4.4 / 5: ★★★★★		★★★★★	Stocks, Options, ETFs, Cryptocurrency	$0	$0	1.5%	Get a free stock when you successfully sign up and link your bank account.	Trade stocks, options, ETFs and crypto without commissions on a user-friendly platform and earn 1.5% APY on your uninvested cash.	Go to site More Info		loading Fetching your data...

loading

CompareClear

More on investing

How to buy FAANG stocks

Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.

Read more…

How to buy soccer stocks

A simple guide to buying stocks in your favorite European soccer team.

Read more…

Inflation stocks

Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.

Read more…